Murray Thomas H
The Hastings Center, 21 Malcolm Gordon Road, Garrison, NY 10524-5555, USA.
Novartis Found Symp. 2005;265:188-96; discussion 196-211.
Though it is possible to discuss the ethics of research with human embryonic stem (ES) cells without any reference to politics, doing so would shed little light on the nature or intensity of the public debate, especially in the USA. Ethical arguments and scientific claims have been appropriated and offered with what appears often to be little regard for their soundness or relevance. In this paper I will discuss: (1) briefly, the history of research ethics and policy regarding human embryos in the US and the UK; (2) the decisions made by the current President of the USA regarding ES cell research, including a critical examination of the ethical arguments offered; (3) the evolution of the debate in which nuclear transplantation in stem cell research has been conflated with cloning to attempt to create a human infant; (4) the stalemate within the US Congress over legislation on cloning; (5) possible developments suggesting that the current US policy on ES cell research may become unstable; and (6) the broader context of the ethical debate and what is at stake for the major protagonists.
尽管在不涉及任何政治因素的情况下讨论人类胚胎干细胞(ES)研究的伦理问题是有可能的,但这样做对于公众辩论的本质或激烈程度几乎没有启示作用,尤其是在美国。伦理观点和科学主张常常被挪用,而且提出时似乎很少考虑其合理性或相关性。在本文中,我将讨论:(1)简要介绍美国和英国关于人类胚胎的研究伦理和政策的历史;(2)美国现任总统就胚胎干细胞研究所做的决定,包括对所提出的伦理观点进行批判性审视;(3)干细胞研究中的核移植与试图克隆人类婴儿的克隆技术被混为一谈的辩论演变过程;(4)美国国会在克隆立法问题上的僵局;(5)表明美国当前胚胎干细胞研究政策可能变得不稳定的潜在发展情况;以及(6)伦理辩论的更广泛背景以及主要参与者所面临的利害关系。